Literature DB >> 15326189

The unusually stable quaternary structure of human Cu,Zn-superoxide dismutase 1 is controlled by both metal occupancy and disulfide status.

Fabio Arnesano1, Lucia Banci, Ivano Bertini, Manuele Martinelli, Yoshiaki Furukawa, Thomas V O'Halloran.   

Abstract

The eukaryotic copper,zinc superoxide dismutases are remarkably stable dimeric proteins that maintain an intrasubunit disulfide bond in the reducing environment of the cytosol and are active under a variety of stringent denaturing conditions. The structural interplay of conserved disulfide bond and metal-site occupancy in human copper,zinc superoxide dismutase (hSOD1) is of increasing interest as these post-translational modifications are known to dramatically alter the catalytic chemistry, the subcellular localization, and the susceptibility of the protein to aggregation. Using biophysical methods, we find no significant change in the gross secondary or tertiary structure of the demetallated form upon reduction of the disulfide. Interestingly, reduction does lead to a dramatic change in the quaternary structure, decreasing the monomer-to-dimer equilibrium constant by at least four orders of magnitude. This reduced form of hSOD1 is monomeric, even at concentrations well above the physiological range. Either the addition of Zn(II) or the formation of the disulfide leads to a shift in equilibrium that favors the dimeric species, even at low protein concentrations (i.e. micromolar range). We conclude that only the most immature form of hSOD1, i.e. one without any post-translational modifications, favors the monomeric state under physiological conditions. This finding provides a basis for understanding the selectivity of mitochondrial SOD1 import and may be relevant to the toxic properties of mutant forms of hSOD1 that can cause the familial form of amyotrophic lateral sclerosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326189     DOI: 10.1074/jbc.M406021200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  101 in total

Review 1.  Specific effects of reactive thiol drugs on mitochondrial bioenergetics.

Authors:  Iseli L Nantes; Tiago Rodrigues; Antonio C F Caires; Rodrigo L O R Cunha; Felipe S Pessoto; César H Yokomizo; Juliana C Araujo-Chaves; Priscila A Faria; Debora P Santana; Carolina G dos Santos
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

2.  Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice.

Authors:  Yoshiaki Furukawa; Ronggen Fu; Han-Xiang Deng; Teepu Siddique; Thomas V O'Halloran
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 3.  Import, maturation, and function of SOD1 and its copper chaperone CCS in the mitochondrial intermembrane space.

Authors:  Hibiki Kawamata; Giovanni Manfredi
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

Review 4.  Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases.

Authors:  Tomohiro Nakamura; Dong-Hyung Cho; Stuart A Lipton
Journal:  Exp Neurol       Date:  2012-07-05       Impact factor: 5.330

5.  Structural basis of Cu, Zn-superoxide dismutase amyloid fibril formation involves interaction of multiple peptide core regions.

Authors:  Masataka Ida; Mizuho Ando; Masayuki Adachi; Asumi Tanaka; Kodai Machida; Kunihiro Hongo; Tomohiro Mizobata; Miho Yoshida Yamakawa; Yasuhiro Watanabe; Kenji Nakashima; Yasushi Kawata
Journal:  J Biochem       Date:  2015-08-29       Impact factor: 3.387

6.  Distinct oxidative cleavage and modification of bovine [Cu- Zn]-SOD by an ascorbic acid/Cu(II) system: Identification of novel copper binding site on SOD molecule.

Authors:  Hiroshi Uehara; Shen Luo; Baikuntha Aryal; Rodney L Levine; V Ashutosh Rao
Journal:  Free Radic Biol Med       Date:  2016-02-10       Impact factor: 7.376

Review 7.  Catalytic antioxidants to treat amyotropic lateral sclerosis.

Authors:  John P Crow
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

8.  Folding of Cu/Zn superoxide dismutase suggests structural hotspots for gain of neurotoxic function in ALS: parallels to precursors in amyloid disease.

Authors:  Anna Nordlund; Mikael Oliveberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

Review 9.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

10.  Species-specific activation of Cu/Zn SOD by its CCS copper chaperone in the pathogenic yeast Candida albicans.

Authors:  Julie E Gleason; Cissy X Li; Hana M Odeh; Valeria C Culotta
Journal:  J Biol Inorg Chem       Date:  2013-09-17       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.